Protective role for properdin in progression of experimental murine atherosclerosis.

Genetic, dietary and immune factors contribute to the pathogenesis of atherosclerosis in humans and mice. Complement activation is an integral part of the innate immune defence but also shapes cellular responses and influences directly triglyceride synthesis. Deficiency of Factor B of the alternativ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tanja Steiner, Lorenza Francescut, Simon Byrne, Timothy Hughes, Archana Jayanthi, Irina Guschina, John Harwood, Katherine Cianflone, Cordula Stover, Sheila Francis
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6e7e2dc8de124d9abcd1e4d12be77a54
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e7e2dc8de124d9abcd1e4d12be77a54
record_format dspace
spelling oai:doaj.org-article:6e7e2dc8de124d9abcd1e4d12be77a542021-11-18T08:26:13ZProtective role for properdin in progression of experimental murine atherosclerosis.1932-620310.1371/journal.pone.0092404https://doaj.org/article/6e7e2dc8de124d9abcd1e4d12be77a542014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24667818/?tool=EBIhttps://doaj.org/toc/1932-6203Genetic, dietary and immune factors contribute to the pathogenesis of atherosclerosis in humans and mice. Complement activation is an integral part of the innate immune defence but also shapes cellular responses and influences directly triglyceride synthesis. Deficiency of Factor B of the alternative pathway (AP) of complement is beneficial in LDLR(-/-) mice fed a high fat diet. The serum glycoprotein properdin is a key positive regulator of the AP but has not been studied in experimental atherosclerosis. Atherosclerosis was assessed after feeding low fat (LFD) or high fat (HFD) Western type diets to newly generated LDLR(-/-) Properdin(KO) (LDLR(-/-)P(KO)) and LDLR-/-PWT mice. Lipids, lymphocytes and monocytes were similar among genotypes, genders and diets. Complement C3, but not C3adesarg, levels were enhanced in LDLR(-/-)P(KO) mice regardless of diet type or gender. Non-esterified fatty acids (NEFA) were decreased in male LDLR(-/-)P(KO) fed a HFD compared with controls. All mice showed significant atherosclerotic burden in aortae and at aortic roots but male LDLR(-/-) mice fed a LFD were affected to the greatest extent by the absence of properdin. The protective effect of properdin expression was overwhelmed in both genders of LDLR(-/-)mice when fed a HFD. We conclude that properdin plays an unexpectedly beneficial role in the development and progression of early atherosclerotic lesions.Tanja SteinerLorenza FrancescutSimon ByrneTimothy HughesArchana JayanthiIrina GuschinaJohn HarwoodKatherine CianfloneCordula StoverSheila FrancisPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 3, p e92404 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tanja Steiner
Lorenza Francescut
Simon Byrne
Timothy Hughes
Archana Jayanthi
Irina Guschina
John Harwood
Katherine Cianflone
Cordula Stover
Sheila Francis
Protective role for properdin in progression of experimental murine atherosclerosis.
description Genetic, dietary and immune factors contribute to the pathogenesis of atherosclerosis in humans and mice. Complement activation is an integral part of the innate immune defence but also shapes cellular responses and influences directly triglyceride synthesis. Deficiency of Factor B of the alternative pathway (AP) of complement is beneficial in LDLR(-/-) mice fed a high fat diet. The serum glycoprotein properdin is a key positive regulator of the AP but has not been studied in experimental atherosclerosis. Atherosclerosis was assessed after feeding low fat (LFD) or high fat (HFD) Western type diets to newly generated LDLR(-/-) Properdin(KO) (LDLR(-/-)P(KO)) and LDLR-/-PWT mice. Lipids, lymphocytes and monocytes were similar among genotypes, genders and diets. Complement C3, but not C3adesarg, levels were enhanced in LDLR(-/-)P(KO) mice regardless of diet type or gender. Non-esterified fatty acids (NEFA) were decreased in male LDLR(-/-)P(KO) fed a HFD compared with controls. All mice showed significant atherosclerotic burden in aortae and at aortic roots but male LDLR(-/-) mice fed a LFD were affected to the greatest extent by the absence of properdin. The protective effect of properdin expression was overwhelmed in both genders of LDLR(-/-)mice when fed a HFD. We conclude that properdin plays an unexpectedly beneficial role in the development and progression of early atherosclerotic lesions.
format article
author Tanja Steiner
Lorenza Francescut
Simon Byrne
Timothy Hughes
Archana Jayanthi
Irina Guschina
John Harwood
Katherine Cianflone
Cordula Stover
Sheila Francis
author_facet Tanja Steiner
Lorenza Francescut
Simon Byrne
Timothy Hughes
Archana Jayanthi
Irina Guschina
John Harwood
Katherine Cianflone
Cordula Stover
Sheila Francis
author_sort Tanja Steiner
title Protective role for properdin in progression of experimental murine atherosclerosis.
title_short Protective role for properdin in progression of experimental murine atherosclerosis.
title_full Protective role for properdin in progression of experimental murine atherosclerosis.
title_fullStr Protective role for properdin in progression of experimental murine atherosclerosis.
title_full_unstemmed Protective role for properdin in progression of experimental murine atherosclerosis.
title_sort protective role for properdin in progression of experimental murine atherosclerosis.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/6e7e2dc8de124d9abcd1e4d12be77a54
work_keys_str_mv AT tanjasteiner protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT lorenzafrancescut protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT simonbyrne protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT timothyhughes protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT archanajayanthi protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT irinaguschina protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT johnharwood protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT katherinecianflone protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT cordulastover protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
AT sheilafrancis protectiveroleforproperdininprogressionofexperimentalmurineatherosclerosis
_version_ 1718421808360718336